Celldex Therapeutics | CLDX - Ativos





Ativos Alterar Data
AbbVie USD 136.46B 2.5B 2026-03
Agenus USD 186.46M 40.34M 2026-03
Amgen USD 92.5B 1.92B 2026-03
Bristol-Myers Squibb USD 86.48B 3.56B 2026-03
Celldex Therapeutics USD 511.25M 71.73M 2026-03
Glaxosmithkline GBP 82.34B 102.25M 2025-12
Nektar Therapeutics USD 280.41M 20.94M 2025-12
Northwest Biotherapeutics USD 30.61M 1.06M 2025-09
Pfizer USD 207.62B 542M 2026-03
Rigel Pharmaceuticals USD 242.53M 35.8M 2025-09
Roche Holding CHF 100.7B 5.94B 2025-12